Publications from Johnson & Johnson, page 5
A filtered view. Show the full list.
Refine
Listings
-
Clinical trial reportEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleHeart rhythm
Post-AF ablation anticoagulation: Real-world practice and predictors of therapy
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of the American Academy of Dermatology
Angiokeratomas
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of the American Academy of Dermatology
Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of the American Academy of Dermatology
Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJACC. Advances
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
Development and optimization of a mobile affinity selection chromatography method for analysis of therapeutic monoclonal antibody aggregates in the presence of human serum albumin
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ReviewJournal of controlled release : official journal of the Controlled Release Society
Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives
Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson, Merck & Co. Affiliation source
-
Clinical trial reportJournal of hepatology
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJHLT open
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of the neurological sciences
Serological testing patterns among individuals newly diagnosed with myasthenia gravis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
LetterTransplantation and cellular therapy
A Comparative Analysis of Skin Responses per 2014 NIH Response Criteria and Modified 2025 NIH Skin Task Force Response Criteria in Patients With Sclerotic Chronic Graft-Versus-Host Disease
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
LetterJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
Clinical trial reportLung cancer (Amsterdam, Netherlands)
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportLung cancer (Amsterdam, Netherlands)
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportLung cancer (Amsterdam, Netherlands)
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportMultiple sclerosis and related disorders
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleMolecular therapy. Advances
Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticlePulmonary pharmacology & therapeutics
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleRespiratory medicine
Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewResearch and practice in thrombosis and haemostasis
A review of the pharmacokinetics, pharmacodynamics, efficacy, and safety of direct oral anticoagulants in patients undergoing bariatric surgery
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleToxicology in vitro : an international journal published in association with BIBRA
Harnessing human colonoid-derived monolayers as an in vitro platform for investigating accumulation, toxicity, and pharmacodynamics of small molecules
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleUrology
Homologous Recombination Repair Mutations, Next-generation Sequencing Testing, and Treatment Progression by Race Among Patients With Metastatic Castration-sensitive Prostate Cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Public healthAdded